基于“血水相关”辨治糖尿病肾病的 “虚热湿瘀”病机探讨
Discussion on the Pathogenesis of “Deficiency, Heat, Dampness and Stasis” in Diabetic Nephropathy Based on the Theory of “Correlation between Blood and Water”
DOI: 10.12677/acm.2026.1652037, PDF,   
作者: 郭宇航:黑龙江中医药大学研究生院,黑龙江 哈尔滨;栾仲秋*:黑龙江中医药大学附属第一医院肾病一科,黑龙江 哈尔滨
关键词: 糖尿病肾病血水相关血水同治虚热湿瘀病机辨证论治Diabetic Nephropathy Correlation between Blood and Water Simultaneous Treatment of Blood and Water Deficiency Heat Dampness and Stasis Pathogenesis Syndrome Differentiation and Treatment
摘要: 本研究通过理论阐释与文献梳理,以中医“血水相关”学说为切入点,深入剖析糖尿病肾病(DN)“虚、热、湿、瘀”四大核心病理机制的内在联系。依据疾病发展过程中血水失衡的主次矛盾,构建了“血水同治”的分期诊疗体系,旨在为临床实践提供理论支撑。针对DN复杂的致病过程,“血水理论”提供了关键的解读视角。该病的根本源于脾肾两虚(虚);正气亏损致使水饮内停(湿);水湿久滞则郁而发热(热);最终酿成血水交结、肾络瘀阻(瘀)。这四大因素相互胶结,共同构成了DN的基础病理状态。随着病情进展,上述病机呈现出明显的动态演变规律。早期主要表现为“水病为先”,治宜健脾化气、利水兼以和血。中期逐渐发展成“血水同病”,此时须扶正与祛邪并举,采取益气养阴补血,或温阳活血利水之法。及至晚期,“血病入络”成为主导,治疗重心应转向温阳降浊与化瘀通络,并辅以利水。在方药应用上,桂枝茯苓丸便是践行“活血、利水、调气”同治理念的典型代表。综上所述,以“血水理论”指导DN治疗,不仅能精准把握病机本质,其衍生出的分期策略更具备极高的临床实用价值。后续亟待引入现代科技手段深化其微观机制的研究,并依托高质量的临床试验来验证相关方剂的确切疗效。
Abstract: Through theoretical interpretation and literature review, this study takes the traditional Chinese medical theory of “correlation between blood and water” as a breakthrough point to deeply analyze the internal connections among the four core pathological mechanisms of “deficiency, heat, dampness and stasis” in diabetic nephropathy (DN). Based on the primary and secondary contradictions of blood-water imbalance during disease progression, this study constructs a staged diagnosis and treatment system based on the principle of “simultaneous treatment of blood and water”, aiming to provide theoretical support for clinical practice. The “blood-water theory” offers a crucial interpretive perspective for the complex pathogenesis of DN. The fundamental cause of the disease lies in the deficiency of both spleen and kidney (deficiency); the deficiency of healthy qi leads to the internal retention of water-fluid (dampness); prolonged stagnation of water-dampness transforms into heat after depression (heat); and eventually results in the entanglement of blood and water and the obstruction of renal collaterals by blood stasis (stasis). These four pathogenic factors interact and intertwine with each other, jointly forming the basic pathological state of DN. With the progression of the disease, the above-mentioned pathogenesis presents an obvious dynamic evolution law. In the early stage, the main manifestation is “water disease as the priority”, and the treatment should focus on invigorating spleen and regulating qi, promoting diuresis and harmonizing blood. In the middle stage, it gradually develops into “concurrent disease of both blood and water”, at which time both strengthening healthy qi and eliminating pathogenic factors should be implemented, and the methods of supplementing qi, nourishing yin and tonifying blood, or warming yang, activating blood and promoting diuresis should be adopted. In the late stage, “blood disease entering collaterals” becomes dominant, and the therapeutic focus should be shifted to warming yang for descending turbidness, removing stasis and unblocking collaterals, supplemented by promoting diuresis. In terms of prescription application, Guizhi Fuling Wan is a typical representative that implements the therapeutic concept of simultaneous treatment of “activating blood, promoting diuresis and regulating qi”. In conclusion, guiding the treatment of DN with the “blood-water theory” can not only accurately grasp the essence of pathogenesis, but also the derived staging strategy has extremely high clinical practical value. It is urgent to introduce modern scientific and technological means to deepen the research on its microcosmic mechanism, and rely on high-quality clinical trials to verify the exact efficacy of related prescriptions.
文章引用:郭宇航, 栾仲秋. 基于“血水相关”辨治糖尿病肾病的 “虚热湿瘀”病机探讨[J]. 临床医学进展, 2026, 16(5): 2265-2272. https://doi.org/10.12677/acm.2026.1652037

参考文献

[1] 沈佳丽, 杨晓宇, 张颖煜, 陈彦霖, 易岚, 周恩超, 高坤. 国医大师邹燕勤从虚、热、湿、瘀论治糖尿病肾病[J]. 湖南中医药大学学报, 2022, 42(4): 528-531.
[2] 黄浠睿, 吴清杰, 居睿, 吴长汶, 杨梦晗, 高碧珍. 基于《金匮要略》“血水”理论探讨桂枝茯苓丸临床应用[J]. 中医药通报, 2025, 24(7): 31-34.
[3] 俞操, 张阳, 徐冰, 朱宇轩, 章杰, 李亚妤. 基于“血水同源”理论探析慢性肾脏病3期的论治[J]. 中华养生保健, 2025, 43(2): 82-85.
[4] 常瑞婷, 陈玉鹏, 张珊, 王皓朔, 倪青. 基于“血水同治”理论探析经方辨治糖尿病肾病的思路与应用[J]. 吉林中医药, 2025, 45(3): 282-287.
[5] 高彦彬, 刘铜华, 李平. 糖尿病肾病中医防治指南[J]. 中国中医药现代远程教育, 2011, 9(4): 151-153.
[6] 马千, 程荣菲, 谢桂香. 赵纪生从“虚、风、湿、热、瘀”论治肾炎的经验[J]. 国医论坛, 2018, 33(2): 26-27.
[7] 郭弋凡, 薛泰骑, 张宁. 张宁教授从“风、湿、热、瘀、虚”分期辨治慢性肾小球肾炎[J]. 现代中西医结合杂志, 2025, 34(3): 383-387.
[8] 冯雪, 陈小娟, 王新慧, 余仁欢. 余仁欢基于气血水理论分阶段治疗慢性肾脏病探析[J]. 山东中医杂志, 2025, 44(6): 615-619.
[9] 陈茂盛, 金娟, 刘岳明, 刘琳, 林波, 张维, 何强. 基于病理学分期的糖尿病肾病中医辨证分型研究[J]. 中华中医药学刊, 2016, 34(11): 2668-2672.
[10] 高世荣. 桂枝茯苓丸药理及临床应用综述[J]. 河南中医, 2016, 36(2): 358-359.
[11] 满玉晶, 张萌, 吴效科, 赵春蕾, 苗琪. 桂枝茯苓丸的药理作用及其临床应用[J]. 中医临床研究, 2017, 9(28): 141-143.
[12] 周小祝, 莫志贤. 桂枝茯苓丸的药理作用研究进展[J]. 医药导报, 2006, 25(2): 142-143.
[13] Yu, Z., Che, Y., Ma, M., Jiao, X., Qin, D., Ji, S., et al. (2026) Cinnamaldehyde Ameliorates Diabetic Kidney Disease via Anti-Inflammatory Effects: Bridging Traditional Use and Molecular Mechanisms. European Journal of Pharmacology, 1020, Article ID: 178783. [Google Scholar] [CrossRef
[14] Cai, R., Li, C., Zhao, Y., Yuan, H., Zhang, X., Liang, A., et al. (2025) Traditional Chinese Medicine in Diabetic Kidney Disease: Multifaceted Therapeutic Mechanisms and Research Progress. Chinese Medicine, 20, Article No. 95. [Google Scholar] [CrossRef] [PubMed]
[15] Hu, X., Wang, Z. and Zhang, L. (2025) Investigating Potential Targets of Wulingsan in Diabetic Nephropathy through Network Pharmacology and Experimental Validation. Frontiers in Molecular Biosciences, 12, Article ID: 1647796. [Google Scholar] [CrossRef] [PubMed]
[16] Yi, Z., Yang, B., Wan, F., Lu, J., Liu, D., Lin, L., et al. (2024) Chinese Medicine Linggui Zhugan Formula Protects against Diabetic Kidney Disease in Close Association with Inhibition of Proteinase 3-Mediated Podocyte Apoptosis in Mice. Journal of Ethnopharmacology, 335, Article ID: 118650. [Google Scholar] [CrossRef] [PubMed]
[17] 中华中医药学会, 北京中医药大学东直门医院, 北京中医药大学. 糖尿病肾脏疾病中西医结合诊疗指南[J]. 北京中医药大学学报, 2024, 47(4): 580-592.
[18] 倪青, 王久玉, 庞晴, 等. 糖尿病肾脏病中西医结合防治指南[J]. 环球中医药, 2025, 18(8): 1731-1740.
[19] Chen, Y., Huang, G., Qin, T., Zhang, Z., Wang, H., Xu, Y., et al. (2024) Ferroptosis: A New View on the Prevention and Treatment of Diabetic Kidney Disease with Traditional Chinese Medicine. Biomedicine & Pharmacotherapy, 170, Article ID: 115952. [Google Scholar] [CrossRef] [PubMed]
[20] 中国中西医结合学会内分泌专业委员会糖尿病肾脏病专家委员会, 中国微循环学会中医与微循环专业委员会, 余江毅. 糖尿病肾脏病中西医结合防治专家共识(2023版) [J]. 中华糖尿病杂志, 2023, 15(8): 690-702.
[21] 林子桐, 张超, 沈雪梅. 糖尿病肾病发病机制研究进展[J]. 中国药理学与毒理学杂志, 2014, 28(5): 765-773.
[22] Kato, M. and Natarajan, R. (2019) Epigenetics and Epigenomics in Diabetic Kidney Disease and Metabolic Memory. Nature Reviews Nephrology, 15, 327-345. [Google Scholar] [CrossRef] [PubMed]
[23] Matoba, K., Takeda, Y., Nagai, Y., Yokota, T., Utsunomiya, K. and Nishimura, R. (2020) Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease. Biomedicines, 8, Article No. 40. [Google Scholar] [CrossRef] [PubMed]